Beijing's diagnosis-related group payment reform pilot: Impact on quality of acute myocardial infarction care.

Citation metadata

Date: Dec. 2019
From: Social Science & Medicine(Vol. 243)
Publisher: Elsevier Science Publishers
Document Type: Report; Brief article
Length: 349 words

Document controls

Main content

Abstract :

Keywords Diagnosis-related group; Quality of care; Acute myocardial infarction; China Highlights * Reforming fee-for-service payment systems to DRG payment may slow quality gains. * Process quality indicators instead of outcome quality indicators are affected by DRG payment. * In addition to changing payment methods, reforms should include building a system supporting quality improvement and incorporate process quality indicators as evaluation metrics. Abstract In 2012, China's first diagnosis-related group (DRG) payment system was piloted in Beijing. This study explored whether this payment pilot improved quality and reduced costs of acute myocardial infarction (AMI) care in hospitals implementing DRG payment as compared to control hospitals. A difference-in-difference study design was used with regression and considered several quality indicators including aspirin at arrival, aspirin at discharge, [beta]-blocker at arrival, [beta]-blocker at discharge, statin at discharge, in-hospital mortality, and 30-day readmission rates. DRG payment mechanisms without specific mechanisms to promote care quality did not improve quality of AMI care. Future studies should study the impact of cost control mechanisms together with quality improvement efforts to assess how quality of care may be improved within the Chinese healthcare system. These lessons would be helpful to share with lower-middle-income countries undergoing rapid development that are transitioning to a significantly higher burden of non-communicable diseases. Author Affiliation: (a) Department of Health Policy and Management, School of Public Health, Peking University Health Science Center, China (b) Department of Medical Informatics, School of Basic Medicine, Peking University Health Science Center, China (c) Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, UK (d) Department of Medicine, George Washington School of Medicine & Health Sciences, Washington, DC, United States (e) Nossal Institute for Global Health, Melbourne School of Population and Global Health, University of Melbourne, Australia * Corresponding author. Department of Medicine, George Washington School of Medicine and Health Sciences, 900 23rd Street, NW3,4, Washington, DC, 20037, United States. Article History: Received 9 November 2018; Revised 29 September 2019; Accepted 4 October 2019 Byline: Weiyan Jian (a), Ming Lu (b), Guofeng Liu (a), Kit Yee Chan (c,e), Adrienne N. Poon [apoon@gwu.edu] (c,d,*)

Source Citation

Source Citation   

Gale Document Number: GALE|A605605425